Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

Status:
NOT_YET_RECRUITING

Trial end date:
2026-06-30

Target enrollment:

Participant gender:

This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD

PHASE3

Onconic Therapeutics Inc.